| 801/1507 | US=27 / Imagem Lukka H. Fractionation schemes with IGRT for clinically localized prostate cancer. In: Valicenti RK, Dicker AP, Jaffray DA. Image-guided radiation therapy of prostate cancer. New York: Informa Helthcare, 2008. p. 197-211. ISBN 978-1-420-06078-2. IMAGEM; CANCER DE PROSTATA; RADIOTERAPIA GUIADA POR IMAGEM; RADIOBIOLOGIA; FRACIONAMENTO |
| 802/1507 | US=27 / Imagem Vargas CE, Palta JR, Indelicato D, Li Z. Image-guided proton beam radiation therapy for prostate cancer. In: Valicenti RK, Dicker AP, Jaffray DA. Image-guided radiation therapy of prostate cancer. New York: Informa Helthcare, 2008. p. 213-31. ISBN 978-1-420-06078-2. IMAGEM; CANCER DE PROSTATA; RADIOTERAPIA GUIADA POR IMAGEM; TERAPIA COM FEIXE DE PROTONS; TERAPIA DE PROTONS COM INTENSIDADE MODULADA |
| 803/1507 | US=27 / Imagem Khoo VS, Dearnaley DP. The testing of prostate IGRT in clinical trials. In: Valicenti RK, Dicker AP, Jaffray DA. Image-guided radiation therapy of prostate cancer. New York: Informa Helthcare, 2008. p. 233-47. ISBN 978-1-420-06078-2. IMAGEM; CANCER DE PROSTATA; RADIOTERAPIA GUIADA POR IMAGEM; TESTE DE PROSTATA; IGRT; ENSAIOS CLINICOS |
| 804/1507 | US=27 / Imagem Wiesmeyer M, Saleh H, Murphy M, Anscher MS, Beyer GP, Scarantino CW, Cygler JE. Future developments I: online dosimetric verification with fiducial dosimeter planning and verification. In: Valicenti RK, Dicker AP, Jaffray DA. Image-guided radiation therapy of prostate cancer. New York: Informa Helthcare, 2008. p. 249-68. ISBN 978-1-420-06078-2. IMAGEM; CANCER DE PROSTATA; DOSIMETRIA ONLINE; DOSIMETRIA FIDUCIAL |
| 805/1507 | US=3 / Dermatologia Rossi R, Lotti T, Rashid RM, Liu SW, Alam M. Photodynamic therapy. In: Nouri K, editor. Skin cancer. New York: MacGraw-Hill, 2008. p. 549-61. ISBN 978-0-07-147256-2. |
| 806/1507 | US=27 / Imagem Xiao Y, Podder T, Dicker AP, Yu Y. Future developments II: dose painting with functional imaging, online dose tracking and adaptation, IMRT with robotic brachytherapy, and other nonradiation modalities. In: Valicenti RK, Dicker AP, Jaffray DA. Image-guided radiation therapy of prostate cancer. New York: Informa Helthcare, 2008. p. 269-84. ISBN 978-1-420-06078-2. IMAGEM; CANCER DE PROSTATA; IMAGEM FUNCIONAL; MONITORAMENTO ON-LINE; DOSE DE ADAPTACAO; IMRT; RADIOTERAPIA COM INTENSIDADE MODULADA; BRAQUITERAPIA ROBOTICA |
| 807/1507 | US=3 / Dermatologia Wolfson AH, Lotti TM, Campolmi P, Rossi R. Photodynamic therapy. In: Nouri K, editor. Skin cancer. New York: MacGraw-Hill, 2008. p. 562-75. ISBN 978-0-07-147256-2. TERAPIA FOTODINAMICA; RADIOTERAPIA PARA CANCER DE PELE NAO MELANOMA; RADIOTERAPIA PARA CANCER DE PELE MELANOMA; RADIOTERAPIA PARA CARCINOMA DE CELULAS DE MERKEL |
| 808/1507 | US=32 / Imagem Konski A. Economic considerations of PET scanning in diagnosis, staging, and radiation therapy treatment planning. In: Paulino AC, Teh BS. Pet-CT in radiotherapy treatment planning. Philadelphia: Saunders Elsevier, 2008. p. 249-53. ISBN 978-1-4160-3224-3. |
| 809/1507 | US=33 / Gastro Withers HR. Gastrointestinal cancer management: biological aspects of radiation therapy. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 69-80. ISBN 978-0-7817-7617-2. |
| 810/1507 | US=33 / Gastro Saltz LB. Systemic therapy for metastatic colorectal cancer. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 617-30. ISBN 978-0-7817-7617-2. CANCER COLORRETAL METASTATICO; TERAPIA SISTEMICA; QUIMIOTERAPIA CITOTOXICA; AGENTE RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO |
| 811/1507 | US=39 / Câncer Vollmers HP, Brändlein S. Sensitization of epithelial cancer cells with human monoclonal antibodies. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 3-11. ISBN 978-1-58829-989-5. CELULAS CANCEROSAS EPITELIAIS; ANTICORPOS MONOCLONAIS HUMANOS; ANTICORPOS NATURAIS IGM; FATOR DE RECEPTORES DE CRESCIMENTO; FATOR DE ACELERACAO DO DECAIMENTO; PROTEINAS DE CHOQUE TERMICO |
| 812/1507 | US=39 / Câncer Daniels TR, Neacato IL, Helguera G, Penichet ML. Targeting the transferrin receptor to overcome resistance to anti-cancer agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 13-27. ISBN 978-1-58829-989-5. RECEPTORES-ALVO; TRANSFERRINA; AGENTES ANTICANCERIGENOS; QUIMIORRESISTENCIA |
| 813/1507 | US=39 / Câncer Bonavida B, Jazirehi AR, Vega MI, Huerta-Yepez S, Umezawa K, Suzuki E. Chemo-immunosensitization of resistant B-NHL as a result of rituximab (anti-CD20 mAb)-mediated inhibition of cell survival signaling pathaways. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 29-39. ISBN 978-1-58829-989-5. SENSIBILIZACAO IMUNITARIO; B-NHL; RITUXIMABE; ANTI-CD20 MAB; SINALIZACAO CELULAR |
| 814/1507 | US=39 / Câncer Yoshida T, Sakai T. Agents that regulate DR5 and sensitivity to TRAIL. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 41-9. ISBN 978-1-58829-989-5. |
| 815/1507 | US=39 / Câncer Motarjemi M, Hallett WHD, Li M, Murphy WJ. Proteasome inhibition: potential for sensitization of immune effector mechanisms in cancer. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 51-60. ISBN 978-1-58829-989-5. INIBICAO DO PROTEASSOMA; SENSIBILIZACAO DE MECANISMOS EFETORES IMUNES; CANCER; BORTEZOMIBE; CDDO |
| 816/1507 | US=39 / Câncer Francia G, Emmenegger U, Kerbel RS. Angiogenesis inhibitors as enabling agents for the chemotherapeutic treatment of metastatic disease. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 63-80. ISBN 978-1-58829-989-5. INIBIDORES DA ANGIOGENESE; TRATAMENTO QUIMIOTERAPEUTICO; DOENCA METASTATICA |
| 817/1507 | US=39 / Câncer McCubrey JA, Franklin RA, Bertrand FE, Taylor JR, Chappell WH, Sokolosky ML, Wong EWT, Abrams SL, Stadelman KM, Misaghian N, Ludwing DL, Basecke J, Libra M, Stivala F, Milella M, Tafuri A, Martelli AM, Lunghi P, Bonati A, Terrian DM, Lehmann BD, Steelman LS. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK and PI3K/Akt pathways to sensitize cancer cells to therapy. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 81-114. ISBN 978-1-58829-989-5. SEGMENTACAO CASCATAS DE SOBREVIVENCIA; ATIVACAO DE RAS / RAF / MEK / ERK; VIAS PI3K/AKT; SENSIBILIZACAO DAS CELULAS CANCEROSAS; APOPTOSE; CANCER HEMATOPOIETICO |
| 818/1507 | US=39 / Câncer Rosato RR, Grant S. Histone deacetylase inhibitors and anticancer activity. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 115-31. ISBN 978-1-58829-989-5. INIBIDORES HISTONA DEACETILASE; ATIVIDADE ANTICANCER; MECANISMO MOLECULAR; EPIGENETICA |
| 819/1507 | US=39 / Câncer Sorokin A. Eicosanoids and resistance of cancer cells to chemotherapeutic agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 133-56. ISBN 978-1-58829-989-5. EICOSANOIDES; RESISTENCIA DAS CELULAS CANCEROSAS; AGENTES QUIMIOTERAPEUTICOS; SINTESE CELULAR DE EICOSANOIDES; ACIDO ARAQUIDONICO |
| 820/1507 | US=39 / Câncer Chatterjee D, Sabo E, Resnick MB, Yeung KC, Chin YE. The RKIP and STAT3 axis in cancer chemotherapy: opposites attract. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 159-74. ISBN 978-1-58829-989-5. RKIP; STAT3; QUIMIOTERAPIA; CANCER; APOPTOSE; NF-KB; VIA JAK/STAT; RKIP |